Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Jing-Jin Electric Technologies
688280
5
Hangzhou Anysoft Information Technology
300571
US Stock MarketDetailed Quotes
MDCX Medicus Pharma
- 4.090
- +0.140+3.54%
Close Apr 28 16:00 ET
- 4.090
- 0.0000.00%
Post 16:05 ET
54.87MMarket Cap-3.53P/E (TTM)
4.770High3.750Low134.14KVolume4.240Open3.950Pre Close557.66KTurnover2.34%Turnover RatioLossP/E (Static)13.41MShares5.00052wk High17.48P/B23.47MFloat Cap1.80052wk Low--Dividend TTM5.74MShs Float5.000Historical High--Div YieldTTM25.82%Amplitude1.800Historical Low4.157Avg Price1Lot Size
Medicus Pharma News
Small Cap Wrap: Medicus Pharma, Arizona Gold & Silver, Plug Power...
Market Movers: Nvidia, Plug Power, Medicus Pharma...
Medicus Pharma To Acquire Antev Ltd. For 19% Equity Stake, Or ~2.67M Shares, With Potential $65M In Milestone Payments For Prostate Drug Teverelix
Medicus Pharma to Acquire Antev, Expanding Pipeline With Potentially First-in-class Prostate Treatment | NASDAQ:MDCX
Top Premarket Decliners
Medicus Pharma Ltd's Promising Clinical Developments and Strategic Expansion Drive Buy Rating
Medicus Pharma Expands Basal Cell Carcinoma Study After Encouraging Early Data | NASDAQ:MDCX
Medicus Pharma Is Maintained at Buy by D. Boral Capital
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
This Millrose Properties Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
Express News | D. Boral Capital Initiates Coverage On Medicus Pharma With Buy Rating, Announces Price Target of $14
Medicus Pharma Analyst Ratings
AI replacing animal experiments? A message from the FDA has left "monkey breeders" feeling devastated, and experts state that "we are still far from the stage of implementation."
① The news that the USA FDA has publicly stated it will gradually replace animal testing requirements has led to an increase in the stock prices of AI pharmaceutical companies, impacting traditional drug evaluation CRO companies; ② Some believe this action represents a trend in Industry development. However, others believe that it is far from being implementable.
10-K: FY2024 Annual Report
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Medicus Pharma Secures $4.2 Million for Innovative Skin Treatment Trials
Medicus Pharma Ltd: Promising Phase 2 Results and Market Potential Drive Buy Rating
Medicus Pharma Unveils Pricing of Financing to Advance Skin Cancer Treatment | NASDAQ:MDCX
Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering
Clinical Study SKNJCT-003 Shows Positive Trends as Company Advances Skin Cancer Research in UAE | NASDAQ:MDCX
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 28 18:10
Warren Buffett Stands Tall as U.S. Stocks Tumble: How the 'Oracle' Is Tackling Tariff Impacts?
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
